Nathaniel L Jones1,2, Jay Schulkin3,4, Renata R Urban3, Jason D Wright1,2,5, William M Burke1,2,5, June Y Hou1,2,5, Cora A McElwain4, Ana I Tergas1,2,5,6. 1. a Department of Obstetrics and Gynecology , Columbia University College of Physicians and Surgeons , New York , New York , USA. 2. b New York Presbyterian Hospital , New York , New York , USA. 3. c Department of Obstetrics and Gynecology , University of Washington , Seattle , Washington , USA. 4. d Research Department , American College of Obstetricians and Gynecologists , Washington, DC , USA. 5. e Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons , New York , New York , USA. 6. f Department of Epidemiology , Mailman School of Public Health, Columbia University , New York , New York , USA.
Abstract
BACKGROUND: Opportunistic bilateral salpingectomy (OBS) has been proposed as an ovarian cancer risk-reducing strategy. METHODS: A survey was emailed to 300 members of the American College of Obstetricians and Gynecologists. RESULTS: 125 (42%) surveys were returned: 60% female, 88% generalists, 67% private practice. Only 36% correctly identified the lifetime risk of ovarian cancer, only 23% understood the risk-reducing benefit of bilateral salpingo-oophorectomy. 75% perform salpingectomy during hysterectomy, 26-53% use for sterilization depending on approach. Concerns were increased operative time and complications. For BRCA mutations, 64% recommend BSO, 12% recommend a two-step risk-reducing strategy, and 14% refer to gynecologic oncology. CONCLUSIONS: We identified broad support and factors limiting willingness to perform OBS.
BACKGROUND: Opportunistic bilateral salpingectomy (OBS) has been proposed as an ovarian cancer risk-reducing strategy. METHODS: A survey was emailed to 300 members of the American College of Obstetricians and Gynecologists. RESULTS: 125 (42%) surveys were returned: 60% female, 88% generalists, 67% private practice. Only 36% correctly identified the lifetime risk of ovarian cancer, only 23% understood the risk-reducing benefit of bilateral salpingo-oophorectomy. 75% perform salpingectomy during hysterectomy, 26-53% use for sterilization depending on approach. Concerns were increased operative time and complications. For BRCA mutations, 64% recommend BSO, 12% recommend a two-step risk-reducing strategy, and 14% refer to gynecologic oncology. CONCLUSIONS: We identified broad support and factors limiting willingness to perform OBS.
Entities:
Keywords:
Ovarian cancer prevention; practice patterns; risk-reducing surgery; salpingectomy
Authors: Miranda P Steenbeek; Laura A M van Lieshout; Johanna W M Aarts; Jurgen M J Piek; Sjors F P J Coppus; Leon F A G Massuger; Rosella P M G Hermens; Joanne A de Hullu Journal: J Gynecol Oncol Date: 2018-04-30 Impact factor: 4.401